secwatch.observer — SEC 8-K summary
======================================

Issuer:     PHIBRO ANIMAL HEALTH CORP (PAHC)
CIK:        0001069899
Form:       8-K
Filed at:   2022-11-09T23:59:59+00:00
Accession:  0001558370-22-017185
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phibro Q1 net income down 41% to $3.9M; lowers FY2023 EPS guidance due to rates, tax
--------------------------------------------------------------------------------

- Q1 net sales $232.5M (+8% YoY); diluted EPS $0.10 (-41%); adjusted diluted EPS $0.21 (-18%).
- Animal Health segment sales $154.9M (+10%); Mineral Nutrition $59.6M (+10%).
- FY2023 guidance: net sales $960M-$1B and adjusted EBITDA $113-$118M (unchanged).
- FY2023 diluted EPS guidance cut to $0.96-$1.06 from $1.11-$1.21; adjusted EPS to $1.21-$1.31 from $1.28-$1.38.
- Adjusted effective tax rate guidance raised to 33% from 30% due to foreign tax credit regulations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069899/000155837022017185/0001558370-22-017185-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069899/000155837022017185/pahc-20221109x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-017185

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer